Cargando…

When to opt for preemptive anticoagulation with SARS-CoV-2 infection in the long-term care facilities

Detalles Bibliográficos
Autores principales: Mujahid, Nadia, Rajan, Ashna, Abul, Yasin, Vura, Naga Venkata Rama Krishna, Neupane, Iva, LaPlante, Kerry, Gravenstein, Stefan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9702642/
https://www.ncbi.nlm.nih.gov/pubmed/36434429
http://dx.doi.org/10.1007/s40520-022-02304-8
_version_ 1784839701082931200
author Mujahid, Nadia
Rajan, Ashna
Abul, Yasin
Vura, Naga Venkata Rama Krishna
Neupane, Iva
LaPlante, Kerry
Gravenstein, Stefan
author_facet Mujahid, Nadia
Rajan, Ashna
Abul, Yasin
Vura, Naga Venkata Rama Krishna
Neupane, Iva
LaPlante, Kerry
Gravenstein, Stefan
author_sort Mujahid, Nadia
collection PubMed
description
format Online
Article
Text
id pubmed-9702642
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Springer International Publishing
record_format MEDLINE/PubMed
spelling pubmed-97026422022-11-28 When to opt for preemptive anticoagulation with SARS-CoV-2 infection in the long-term care facilities Mujahid, Nadia Rajan, Ashna Abul, Yasin Vura, Naga Venkata Rama Krishna Neupane, Iva LaPlante, Kerry Gravenstein, Stefan Aging Clin Exp Res Point of View Springer International Publishing 2022-11-25 2022 /pmc/articles/PMC9702642/ /pubmed/36434429 http://dx.doi.org/10.1007/s40520-022-02304-8 Text en © This is a U.S. Government work and not under copyright protection in the US; foreign copyright protection may apply 2022 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Point of View
Mujahid, Nadia
Rajan, Ashna
Abul, Yasin
Vura, Naga Venkata Rama Krishna
Neupane, Iva
LaPlante, Kerry
Gravenstein, Stefan
When to opt for preemptive anticoagulation with SARS-CoV-2 infection in the long-term care facilities
title When to opt for preemptive anticoagulation with SARS-CoV-2 infection in the long-term care facilities
title_full When to opt for preemptive anticoagulation with SARS-CoV-2 infection in the long-term care facilities
title_fullStr When to opt for preemptive anticoagulation with SARS-CoV-2 infection in the long-term care facilities
title_full_unstemmed When to opt for preemptive anticoagulation with SARS-CoV-2 infection in the long-term care facilities
title_short When to opt for preemptive anticoagulation with SARS-CoV-2 infection in the long-term care facilities
title_sort when to opt for preemptive anticoagulation with sars-cov-2 infection in the long-term care facilities
topic Point of View
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9702642/
https://www.ncbi.nlm.nih.gov/pubmed/36434429
http://dx.doi.org/10.1007/s40520-022-02304-8
work_keys_str_mv AT mujahidnadia whentooptforpreemptiveanticoagulationwithsarscov2infectioninthelongtermcarefacilities
AT rajanashna whentooptforpreemptiveanticoagulationwithsarscov2infectioninthelongtermcarefacilities
AT abulyasin whentooptforpreemptiveanticoagulationwithsarscov2infectioninthelongtermcarefacilities
AT vuranagavenkataramakrishna whentooptforpreemptiveanticoagulationwithsarscov2infectioninthelongtermcarefacilities
AT neupaneiva whentooptforpreemptiveanticoagulationwithsarscov2infectioninthelongtermcarefacilities
AT laplantekerry whentooptforpreemptiveanticoagulationwithsarscov2infectioninthelongtermcarefacilities
AT gravensteinstefan whentooptforpreemptiveanticoagulationwithsarscov2infectioninthelongtermcarefacilities